Compare Enveric Biosciences Inc (ENVB) vs TJX Companies Inc (TJX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs TJX Companies Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while TJX Companies Inc trades at $155.98 (market cap $172.05B). The key difference: TJX Companies Inc is far larger — about 27750× Enveric Biosciences Inc's market cap, and TJX Companies Inc pays a 1.23% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | TJX | |
|---|---|---|
Market Cap | $6.20M | $172.05B |
Sector | Health | Consumer Cyclical |
52-Week High | $17.40 | $168.41 |
52-Week Low | $1.27 | $132.62 |
Enterprise Value | $1.30M | $180.65B |
Dividend Yield | — | 1.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TJX trades at $158.80, down 1.59% on the day, but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $158 and resistance at $160, while analyst consensus remains overwhelmingly positive with 88% buy ratings and a $181.80 price target. Recent financial performance demonstrates solid revenue growth from $48.5B in 2022 to $56.4B in 2025, with net income margins expanding to 8.63%.
TJX presents a compelling investment case with strong operational execution and market share gains in discount retail. The primary upside catalyst is continued earnings outperformance and expansion into new markets, while risks include consumer spending sensitivity and competitive pressures. With projected 2026 revenue of $61.6B and net income of $5.8B, the company's growth trajectory supports the bullish analyst sentiment despite premium valuation multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About TJX Companies Inc
TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.
Read more on TJX →
